Section of Oncology and Hematology

James Armitage, M.D.
Professor, Internal Medicine Section of Hematology & Oncology Academic office: UNMC Oncology/Hematology Section 987680 Nebraska Medical Center Omaha, NE 681980-7680 Main practice location: Peggy D. Cowdery Patient Care Center Lied Transplant Center 987835 Nebraska Medical Center Omaha, NE 68198-7835 Ph. 402-559-7290 Fax 402-559-6520
Education: University of Nebraska Medical Center, Omaha, NE, Intern, (1974) University of Nebraska Medical Center, Omaha, NE, Resident, (1975) University of Nebraska, Lincoln, NE, B.S., (1969) University of Nebraska Medical Center, Omaha, NE, M.D., (1973) University of Iowa Hospitals and Clinics, Iowa City, IA, Fellow, (1977)	Hospital Appointments: The Nebraska Medical Center University Hospital Interests: Management and classification of lymphoma and leukemia Bone marrow transplantation

Academic Rank:Shapiro Professor of Medicine
Department:Internal Medicine

College:College of Medicine

Membership in Societies:

ASCO; ASH, AFCR, ASCR, ASCR, ASBMT, Royal College of Physicians

Biographical Sketch:
Dr. James O. Armitage graduated from the University of Nebraska Medical Center in 1973 where he completed his internship and residency in internal medicine in 1975. In 1977 he completed a fellowship in hematology-oncology at the University of Iowa Hospitals and Clinics, Iowa City, Iowa. Dr. Armitage was in private practice from 1977-79, and in 1979 he returned to the University of Iowa as an Assistant Professor of Medicine, where he developed and was director of the Bone Marrow Transplantation Program. In 1982 he returned to Nebraska as as Associate Professor of Medicine and was promoted in 1987 to Professor of Medicine. He has served as Vice Chairman of the Department of Medicine (1982-90), Chief of the Section of Oncology/Hematology (1986-89), Chairman of the Department of Internal Medicine (1990-99), Dean, College of Medicine (2000-03), and presently holds the position of the Joe Shapiro Professor of Medicine. He is a member of several professional organizations as well as serving on the editorial boards of several peer-reviewed journals. He serves on several national and international committees and served as President of ASCO (1996-97) and President of ASBMT (2000-01). He has authored or co-authored 440 articles, 95 book chapters, more than 450 abstracts, and is the editor/co-editor of 24 books. He is married to Nancy Armitage and the father of four children and grandfather of three grandchildren.

Select Publications:
Armitage JO, Weisenburger DD, Hutchins M, Moravec DF, Dowling M, Sorensen S, Mailliard J, Okerbloom J, Johnson PS, Howe D, Bascom GK, Casey J, Linder J, Purtilo DJ: Chemotherapy for Diffuse Large Cell Lymphomas--Rapidly Responding Patients Have More Durable Remissions.  Journal of Clinical Oncology 4:160-164, 1986.

Kessinger A, Armitage JO, Landmark JD, Weisenburger DD:  Reconstitution of Human Hematopoietic Function with Autologous Cryopreserved Circulating Stem Cells.  Experimental Hematology 14:192-196, 1986

Philip T, Armitage JO, Spitzer G, Chauvin F, Jagannath S, Cahn JY, Colombat P, Goldstone AH, Gorin NC, Flesh M. Laporte JP, Maraninchi D, Pico JL, Bosly A, Anderson C, Schots R, Biron P, Cabanillas F, Dicke K:  High Dose Therapy and Autologous Bone Marrow Transplantation in 100 Adults with Intermediate or High Grade Non-Hodgkin's Lymphoma. N Engl J Med 316:1493-1498, 1987

Kessinger A, Smith DM, Strandjord SE, Landmark JD, Dooley DC, Law P. Coccia PF, Warkentin PI, Weisenburger DD, Armitage JO:  Allogeneic Transplantation of Blood-Derived, T-cell Depleted Hematopoietic Stem Cells after Myeloablative Treatment in Patients with Acute Lymphblastic Leukemia.  Bone Marrow Transplantation 4:643-646, 1989.

Armitage JO, Weisenburger DD:  New Approach to Classifying Non-Hodgkin's Lymphomas:Clinical Features of the Major Histologic Subtypes.  Non-Hodgkin's Lymphoma Classification Project.  J Clin Oncol.16:2780-95, 1998.

Hasenclever D, Diehl V, Armitage JO, Assouline D, Bjorkholm M, Brusamolino E, Canellos Gp, Carde P, Crowther D, Cunningham D, Eghbali H, Ferme C, Fisher RI, Glick JH, Glimelius B, Gobbi PG, holte H, Horning SJ, Lister TA, Longo DL, Mandelli F, Polliack A, Proctor SJ, Specht L, Sweetenham JW, Vaughan Hudson G for the International Prognostic Factors Project on Advanced Hodgkin's Disease: A Prognostic score for advanced Hodgkin's disease. NEJM 339:1506-14, 1998

Allzadeh AA, Elson MB, David RE, MaC, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powel JI, Yang L, Martl GE, Moore T, Hudson J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grover MR, Byrd JC, Boststein D, Brown PO, Staudt LM: Distinct Types of Diffuse Large B-cell Lymphoma Identified by Gene Expression Profiling.  Nature 403:503-511, 2000.

Weekes CD, Vose JM, Lynch JC, Weisenburger DD, Bierman PJ, Greiner T, Bociek G, Enke C, Bast M, Chan WC, Armitage JO for the Nebraska Lymphoma Study Group.  Hodgkin's Disease in the Elderly:  Improved Treatment Outcome Wtih a Doxorubicin-Containing Regimen.  J Clin Oncol 20:1087-1093, 2002.

Vose JM, Sharp G, Chan WC, Nichols C, Loh K, Inwards D, Rifkin R, Bierman PJ, Lynch JC, Weisenburger DD, Kessinger A, Armitage JO: Autologous Transplantation for Aggressive Non-Hodgkin's Lymphoma: Results of Randomized Trial Evaluating Graft Source and Minimal Residual Disease. J Clin Oncol 20:2344-2352, 2002

Ganti AK, Weisenburger DD, Smith LM, Hans CP, Bociek RG, Bierman PJ, Vose JM, Armitage JO. Patients with Grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy. The Nebraska Lymphoma Study Group Experience. Ann Oncol 17:920-927, 2006.

Armitage JO, Bierman PJ, Bociek RG, Vose JM. Lymphoma 2006. Classification and Treatment. Oncology (Williston Park) 20:231-239, 2006.